Incyte Corporation Price Today
Incyte Corporation
INCY
Healthcare
$12.36B
💰
Market Cap
20.8
💸
Price to Earnings
$2.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
9 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
INCY Price Forecast Target
55.0 👉 92.0 +67%
INCY EPS Forecast
2.6 👉 5.4 +105%
Financials
Profit Margin
16 %
Revenue Growth
9.3 %
Dividend
$ 0
Held Percent
1.6% - Insiders
100.2% - Institutions
-1.8% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…📮FAQ
Some Frequently Asked Questions.
The Incyte Corporation industry is Biotechnology
The Incyte Corporation sector is Healthcare
The Incyte Corporation forecasted predicted Price to Earnings PE ratio is 10.2
The Incyte Corporation Price to Earnings PE ratio is 20.8
The Market Capitalization of Incyte Corporation is $12.36B
There are total of 186978624 float shares with 100.2% held by Institutions and 1.6% held by insiders
The MIncyte Corporation forecasted Earnings per Share EPS is $5.4
The Incyte Corporation Earnings per Share EPS is 2.6
The Incyte Corporation company has $0 gross profits with 16 profit margins
The Incyte Corporation Earnings Growth is 6.324% with 6.065% quarterly earnings growth
The Incyte Corporation Revenue is $3695649024 with 0.093 revenue growth
The price target for Incyte Corporation stock is $92.0 for the high target and $61.0 for the low target
The consensus analyst recommendations for Incyte Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Incyte Corporation is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 9
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Incyte Corporation is 0.7
The dividend of Incyte Corporation is $0
The dividend yield of Incyte Corporation is 0%
The biggest institutional and mutual fund holders of Incyte Corporation stock are
The Incyte Corporation ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0